Who owns AKARI THERAPEUTICS PLC SPONSORED?
- Ticker: AKTX
- CUSIP Number: 00972g207
Tip: Access positions for across all investors
Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akari Therapeutics Plc Sponsored stock
Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Omnia Family Wealth | 88k | $259k | 0% | Sep 2024 |
|
| Citadel Advisors | 33k | $99k | 100% | Sep 2024 |
|
| HPM Partners | 24k | $70k | 0% | Sep 2024 |
|
| Renaissance Technologies | 18k | $53k | 6% | Sep 2024 |
|
| Bank of America Corporation | 150.00 | $442.005000 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 100.00 | $295.000000 | 100% | Sep 2024 |
|
| Morgan Stanley | 6.00 | $16.000200 | 0% | Jun 2024 |
|
| Cornerstone Planning Group | 5.00 | $13.000000 | 0% | Sep 2024 |
|
Who sold out of Akari Therapeutics Plc Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Jun 2024 | 17k | $48k |
| Truvestments Capital | Mar 2024 | 50.00 | $93.000000 |